ADVISORY RESEARCH INC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 241 filers reported holding NOVOCURE LTD in Q3 2019. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2022$405,000
+76.1%
4,893
+60.0%
0.03%
+77.8%
Q4 2021$230,000
-82.2%
3,058
-72.4%
0.02%
-78.3%
Q3 2021$1,289,000
-68.0%
11,094
-38.8%
0.08%
-68.7%
Q2 2021$4,024,000
+61.9%
18,140
-3.5%
0.26%
+51.4%
Q1 2021$2,485,000
-43.9%
18,797
-26.6%
0.18%
-46.2%
Q4 2020$4,431,000
-5.1%
25,609
-39.0%
0.32%
-28.6%
Q3 2020$4,670,000
+136.0%
41,956
+25.7%
0.46%
+158.5%
Q2 2020$1,979,000
-21.2%
33,372
-10.5%
0.18%
+1.1%
Q1 2020$2,512,000
-26.6%
37,306
-8.2%
0.17%
+10.8%
Q4 2019$3,423,000
+79.3%
40,618
+59.1%
0.16%
+70.7%
Q3 2019$1,909,000
-59.6%
25,524
-65.9%
0.09%
-1.1%
Q2 2019$4,727,000
+57.2%
74,761
+19.8%
0.09%
+60.3%
Q1 2019$3,007,000
+35.8%
62,417
-5.7%
0.06%
+23.4%
Q4 2018$2,215,000
-54.8%
66,158
-29.2%
0.05%
-41.2%
Q3 2018$4,898,000
+16.2%
93,472
-30.6%
0.08%
+19.4%
Q2 2018$4,216,000
+66.2%
134,710
+15.8%
0.07%
+45.7%
Q1 2018$2,536,000
+20.9%
116,310
+12.0%
0.05%
+31.4%
Q4 2017$2,097,000
-5.1%
103,809
-6.7%
0.04%0.0%
Q3 2017$2,209,000
+57.6%
111,309
+37.3%
0.04%
+59.1%
Q2 2017$1,402,00081,0680.02%
Other shareholders
NOVOCURE LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders